These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39103266)

  • 1. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity].
    Xia Q; Chang XN; Huang B; Li XF; Luo DJ; Wang QJ; Jiang MT; Fan J; Zhou DW
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):837-842. PubMed ID: 39103266
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer.
    Kriegsmann M; Kriegsmann K; Harms A; Longuespée R; Zgorzelski C; Leichsenring J; Muley T; Winter H; Kazdal D; Goeppert B; Warth A
    Diagn Pathol; 2018 Sep; 13(1):68. PubMed ID: 30205833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
    Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
    Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
    Dermawan JKT; Underwood D; Policarpio-Nicolas ML
    Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens.
    Saad M; Cantley R; Hao W; Wang Z; Thomas D; Pantanowitz L; Jin X
    Diagn Cytopathol; 2024 Jul; 52(7):362-368. PubMed ID: 38558495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
    Willis BC; Johnson G; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation.
    Leblond AL; Rechsteiner M; Jones A; Brajkovic S; Dupouy D; Soltermann A
    Am J Clin Pathol; 2019 Jun; 152(1):59-73. PubMed ID: 31065676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale.
    Lefferts JA; Loehrer AP; Yan S; Green DC; Deharvengt SJ; LeBlanc RE
    J Cutan Pathol; 2020 Jun; 47(6):541-547. PubMed ID: 31943331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma.
    Zhu ML; Zhou L; Sadri N
    Virchows Arch; 2018 Sep; 473(3):371-377. PubMed ID: 29926184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics.
    Salimian KJ; Fazeli R; Zheng G; Ettinger D; Maleki Z
    Acta Cytol; 2018; 62(2):79-84. PubMed ID: 29320776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.
    Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE
    Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
    Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA
    Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.
    Bezić J; Tomić I; Pavić M
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow findings in metastatic melanoma, including role of BRAF immunohistochemistry.
    Corean JLE; George TI; Patel JL; Li KD
    Int J Lab Hematol; 2019 Aug; 41(4):550-560. PubMed ID: 31112348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall.
    Van Winden VI; Wong DD; Wood BA; Filion P; Harvey NT
    Pathology; 2024 Feb; 56(1):47-51. PubMed ID: 37989630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.
    McAfee JL; Scarborough R; Jia XS; Azzato EM; Astbury C; Ronen S; Andea AA; Billings SD; Ko JS
    J Cutan Pathol; 2023 Feb; 50(2):155-168. PubMed ID: 36261329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.